The role of photodynamic therapy (PDT) physics

Medical Physics

Volumn 35, Issue 7, 2008, Pages 3127-3136

  Zhu, Timothy C ^a   Finlay, Jarod C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Dynamic process; Explicit dosimetry; Implicit dosimetry; PDT; Spectroscopy

Indexed keywords

DOSIMETRY; PHOTOSENSITIZERS; SPECTROSCOPY;

BIOLOGICAL RESPONSE; BIOPHYSICAL MECHANISM; DYNAMIC PROCESS; MULTI-MODALITY IMAGING; PHOTOCHEMICAL INTERACTIONS; PHOTODYNAMIC THERAPY (PDT); REAL-TIME DOSIMETRY; TECHNICAL DEVELOPMENT;

PHOTODYNAMIC THERAPY;

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID HEXYL ESTER; AMINOLEVULINIC ACID METHYL ESTER; LUTETIUM TEXAPHYRIN; OXYGEN; PALLADIUM BACTERIOPHEOPHORBIDE; PC 4; PHOTOFRIN; PHOTOSENSITIZING AGENT; PROGESTERONE; TALAPORFIN; TEMOPORFIN; VERTEPORFIN;

DOSIMETRY; DRUG CLEARANCE; HUMAN; LIGHT; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

EID: 46149097204     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.2937440     Document Type: Review

References (116)

1. T. J. Dougherty, C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan, and Q. Peng, " Photodynamic therapy.," J. Natl. Cancer Inst. 0027-8874 10.1093/jnci/90.12.889 90, 889-905 (1998).
2. M. A. Biel, " Photodynamic therapy and the treatment of head and neck cancers.," J. Clin. Laser Med. Surg. 14, 239-244 (1996). 1044-5471
3. W. E. Grant, P. M. Speight, C. Hopper, and S. G. Bown, " Photodynamic therapy: an effective, but non-selective treatment for superficial cancers of the oral cavity.," Int. J. Cancer 71, 937-942 (1997). 0020-7136
4. J. S. Friedberg, R. Mick, J. P. Steveson, T. Zhu, T. M. Busch, D. Shin, D. Smith, M. Culligan, A. Dimofte, E. Glatstein, and S. M. Hahn, " A phase II trial of pleural photodynamic therapy (PDT) and surgery for patients with non-small cell lung cancer (NSCLC) with pleural spread.," J. Clin. Oncol. 22, 2192-2201 (2004). 0732-183X
5. T. L. Moskal, T. J. Dougherty, J. D. Urschel, J. G. Antkowiak, A. M. Regal, D. L. Driscoll, and H. Takita, " Operation and photodynamic therapy for pleural mesothelioma: 6-year follow-up.," Ann. Thorac. Surg. 66, 1128-1133 (1998). 0003-4975
6. H. I. Pass, " Intrapleural photodynamic therapy: Results of a phase I trial.," Ann. Surg. Oncol. 1, 28-37 (1994). 1068-9265
7. J. S. Friedberg, R. Mick, J. Stevenson, J. Metz, T. Zhu, J. Buyske, D. H. Sterman, H. I. Pass, E. Glatstein, and S. M. Hahn, " A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma.," Ann. Thorac. Surg. 75, 952-959 (2003). 0003-4975
8. R. Ackroyd, N. J. Brown, M. F. Davis, T. J. Stephenson, S. L. Marcus, C. J. Stoddard, A. G. Johnson, and M. W. Reed, " Photodynamic therapy for dysplastic Barrett's esophagus: A prospective, double blind, randomised, placebo controlled trial.," Gut 0017-5749 10.1136/gut.47.5.612 47, 612-617 (2000).
9. M. Panjehpour, B. F. Overholt, J. M. Haydek, and S. G. Lee, " Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett's esophagus and effect of oral steroids on stricture formation.," Am. J. Gastroenterol. 95, 2177-2184 (2000). 0002-9270
10. T. R. Nathan, D. E. Whitelaw, S. C. Chang, W. R. Lees, P. M. Ripley, H. Payne, L. Jones, M. C. Parkinson, M. Emberton, A. R. Gillams, A. R. Mundy, and S. G. Browen, " Photodynamic therapy for prostate cancer recurrence after radiotherapy: A phase I study.," J. Urol. 168, 1427-1432 (2002). 0022-5347
11. D. Stripp, R. Mick, T. C. Zhu, R. Whittington, D. Smith, A. Dimofte, J. C. Finlay, J. Miles, T. M. Busch, D. Shin, A. Kachur, Z. Tochner, S. B. Malkowicz, E. Glatstein, and S. M. Hahn, " Phase I trial of Motexfin Lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer.," Proc. SPIE 0277-786X 10.1117/12.529181 5315, 88-99 (2004).
12. R. A. Weersink, A. Bogaards, M. Gertner, S. R. Davidson, K. Zhang, G. Netchev, J. Trachtenberg, and B. C. Wilson, " Techniques for delivery and monitoring of TOOKAD (WST09)-mediated photodynamic therapy of the prostate: clinical experience and practicalities.," J. Photochem. Photobiol. B 79, 211-222 (2005). 1011-1344
13. M. A. Rosenthal, B. Kayar, J. S. Hill, D. J. Morgan, R. L. Nation, S. S. Stylli, R. L. Basser, S. Uren, H. Geldard, M. D. Green, S. B. Kahl, and A. H. Kaye, " Phase I and pharmacokinetic study of photodynamic therapy for high-grade gliomas using a noval boronated porphyrin.," J. Clin. Oncol. 19, 519-524 (2001). 0732-183X
14. T. T. Goodell and P. J. Muller, " Photodynamic therapy: A novel treatment for primary brain malignancy.," J. Neurosci. Nurs. 33, 296-300 (2001). 0888-0395
15. A. Bogaards, A. Varma, K. Zhang, D. Zach, S. K. Bisland, E. H. Moriyama, L. Lilge, P. J. Muller, and B. C. Wilson, " Fluorescence image-guided brain tumour resection with adjuvant metronomic photodynamic therapy: Pre-clinical model and technology development.," Photochem. Photobiol. Sci. 1474-905X 10.1039/b414829k 4, 438-442 (2005).
16. M. J. Paterson, O. Christiansen, F. Jensen, and P. R. Ogilby, " Overview of theoretical and computational methods applied to the oxygen-organic molecule photosystem.," Photochem. Photobiol. 0031-8655 10.1562/2006-03-17-IR-851 82, 1136-1160 (2006).
17. T. H. Foster, D. F. Hartley, M. G. Nichols, and R. Hilf, " Fluence rate effects in photodynamic therapy of multicell tumor spheroids.," Cancer Res. 53, 1249-1254 (1993). 0008-5472
18. I. Georgakoudi, M. G. Nichols, and T. H. Foster, " The mechanism of Photofrin photobleaching and its consequences for photodynamic dosimetry.," Photochem. Photobiol. 0031-8655 10.1111/j.1751-1097.1997.tb01889.x 65, 135-144 (1997).
19. S. L. Gibson, K. R. VanDerMeid, R. S. Murant, R. F. Raubertas, and R. Hilf, " Effects of various photoradiation regimens on the antitumor efficacy of photodynamic therapy for R3230AC mammary carcnimoas.," Cancer Res. 50, 7236-7241 (1990). 0008-5472
20. B. W. Henderson, T. M. Busch, L. A. Vaughan, N. P. Frawley, D. Babich, T. A. Sosa, J. D. Zollo, A. S. Dee, M. T. Cooper, D. A. Bellnier, W. R. Greco, and A. R. Oseroff, " Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate.," Cancer Res. 60, 525-529 (2000). 0008-5472
21. B. W. Henderson, T. M. Busch, and J. W. Snyder, " Fluence rate as a modulator of PDT mechanisms.," Lasers Surg. Med. 0196-8092 10.1002/lsm.20327 38, 489-493 (2006).
22. X. H. Hu, Y. Feng, J. Q. Lu, R. R. Allison, R. E. Cuenca, G. H. Downie, and C. H. Sibata, " Modeling of a type II photofrin-mediated photodynamic therapy process in a heterogeneous tissue phantom.," Photochem. Photobiol. 0031-8655 10.1562/2005-05-04-RA-513 81, 1460-1468 (2005).
23. T. C. Zhu, J. C. Finlay, X. Zhou, and J. Li, " Macroscopic modeling of the singlet oxygen production during PDT.," Proc. SPIE 0277-786X 10.1117/12.701387 6427, 642708-642720 (2007).
24. B. C. Wilson and M. S. Patterson, in Photodynamic Therapy of Neoplastic Disease, edited by, D. Kessel, (CRC Press, Boca Raton, 1990), Vol. 1, pp. 129-144.
25. P. R. Almond, Photodynamic Therapy Equipment and Dosimetry (American Institute of Physics, Woodbury, NY, 1992).
26. A. Ishimaru, Wave Propagation and Scattering in Random Media (IEEE, New York, 1997).
27. W. Cong, L. V. Wang, and G. Wang, " Formulation of photon diffusion from spherical bioluminescent sources in an infinite homogeneous medium.," Biomed. Eng. Online 3, 12 (2004). 1475-925X
28. R. C. Haskell, L. O. Svaasand, T. -T. Tsay, T. -C. Feng, M. S. McAdams, and B. J. Tromberg, " Boundary conditions for the diffusion equation in radiative transfer.," J. Opt. Soc. Am. A 11, 2727-2741 (1994).
29. L. Wang, S. L. Jacques, and L. Zheng, " MCML-Monte Carlo modeling of light transport in multi-layered tissues.," Comput. Methods Programs Biomed. 0169-2607 10.1016/0169-2607(95)01640-F 47, 131-146 (1995).
30. J. J. Duderstadt and W. R. Martin, Transport Theory (Wiley, New York, 1979).
31. B. C. Wilson, M. S. Patterson, and L. Lilge, " Implicit and explicit dosimetry in photodynamic therapy: A new paradigm.," Lasers Med. Sci. 12, 182-199 (1997). 0268-8921
32. S. K. Hendren, S. M. Hahn, F. R. Spitz, T. W. Bauer, S. C. Rubin, T. Zhu, E. Glatstein, and D. L. Fraker, " Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors.," Ann. Surg. Oncol. 8, 65-71 (2001). 1068-9265
33. J. P. Marijnissen and W. M. Star, " Performance of isotropic light dosimetry probes based on scattering bulbs in turbid media.," Phys. Med. Biol. 0031-9155 10.1088/0031-9155/47/12/304 47, 2049-2058 (2002).
34. T. G. Vulcan, T. C. Zhu, C. E. Rodriguez, A. Hsi, D. L. Fraker, P. Baas, L. H. Murrer, W. M. Star, E. Glatstein, A. G. Yodh, and S. M. Hahn, " Comparison between isotropic and nonisotropic dosimetry systems during intraperitoneal photodynamic therapy.," Lasers Surg. Med. 0196-8092 10.1002/(SICI)1096-9101(2000)26:3<292::AID-LSM7>3.0.CO;2-T 26, 292-301 (2000).
35. J. P. Marijnissen and W. M. Star, " Calibration of isotropic light dosimetry probes based on scattering bulbs in clear media.," Phys. Med. Biol. 0031-9155 10.1088/0031-9155/41/7/008 41, 1191-1208 (1996).
36. A. H. Hielscher, A. Y. Bluestone, G. S. Abdoulaey, A. D. Klose, J. Lasker, M. Stewart, U. Netz, and J. Beuthan, " Near-infrared diffuse optical tomography.," Dis. Markers 18, 313-337 (2002). 0278-0240
37. A. Li, E. L. Miller, M. E. Kilmer, T. J. Brukilacchio, T. Chaves, J. Stott, Q. Zhang, T. Wu, M. Chorlton, R. H. Moore, D. B. Kopans, and D. A. Boas, " Tomographic optical breast imaging guided by three-dimensional mammography.," Appl. Opt. 0003-6935 10.1364/AO.42.005181 42, 5181-5190 (2003).
38. J. P. Culver, R. Choe, M. J. Holboke, L. Zubkov, T. Durduran, A. Slemp, V. Ntziachristos, B. Chance, and A. G. Yodh, " Three-dimensional diffuse optical tomography in the parallel plane transmission geometry: Evaluation of a hybrid frequency domain/continuous wave clinical system for breast imaging.," Med. Phys. 0094-2405 10.1118/1.1534109 30, 235-247 (2003).
39. M. J. Holboke, B. J. Tromberg, X. Li, N. Shah, J. Fishkin, D. Kidney, J. Butler, B. Chance, and A. G. Yodh, " Three-dimensional diffuse optical mammography with ultrasound localization in a human subject.," J. Biomed. Opt. 1083-3668 10.1117/1.429992 5, 237-247 (2000).
40. S. Srinivasan, B. W. Pogue, S. Jiang, H. Dehghani, C. Kogel, S. Soho, J. J. Gibson, T. D. Tosteson, S. P. Poplack, and K. D. Paulsen, " In vivo hemoglobin and water concentrations, oxygen saturation, and scattering estimates from near-infrared breast tomography using spectral reconstruction.," Acad. Radiol. 13, 195-202 (2006). 1076-6332
41. B. Brooksby, S. Jiang, H. Dehghani, B. W. Pogue, K. D. Paulsen, J. Weaver, C. Kogel, and S. P. Poplack, " Combining near-infrared tomography and magnetic resonance imaging to study in vivo breast tissue: implementation of a Laplacian-type regularization to incorporate magnetic resonance structure.," J. Biomed. Opt. 1083-3668 10.1117/1.2098627 10, 051504-051514 (2005).
42. B. W. Pogue, S. P. Poplack, T. O. McBride, W. A. Wells, K. S. Osterman, U. L. Osterberg, and K. D. Paulsen, " Quantitative hemoglobin tomography with diffuse near-infrared spectroscopy: Pilot results in the breast.," Radiology 218, 261-266 (2001). 0033-8419
43. J. P. Culver, A. M. Siegel, J. J. Stott, and D. A. Boas, " Volumetric diffuse optical tomography of brain activity.," Opt. Lett. 0146-9592 10.1364/OL.28.002061 28, 2061-2063 (2003).
44. J. P. Culver, T. Durduran, D. Furuya, C. Cheung, J. H. Greenberg, and A. G. Yodh, " Diffuse optical tomography of cerebral blood flow, oxygenation, and metabolism in rat during focal ischemia.," J. Cereb. Blood Flow Metab. 0271-678X 10.1097/01.WCB.0000076703.71231.BB 23, 911-924 (2003).
45. Y. Xu, N. Iftimia, H. Jiang, L. L. Key, and M. B. Bolster, " Three-dimensional diffuse optical tomography of bones and joints.," J. Biomed. Opt. 1083-3668 10.1117/1.1427336 7, 88-92 (2002).
46. T. C. Zhu and J. C. Finlay, " Prostate PDT dosimetry.," Photodiagnosis Photodynamic Therapy 3, 234-246 (2006).
47. X. Zhou, T. C. Zhu, J. C. Finlay, J. Li, A. Dimofte, and S. Hahn, " Two-dimensional/three dimensional hybrid interstitial diffuse optical tomography of human prostate during photodynamic therapy: Phantom and clinical results.," Proc. SPIE 0277-786X 10.1117/12.701717 6434, 64341Y-64352Y (2007).
48. C. Li, R. Liengsawangwong, H. Choi, and R. Cheung, " Using a priori structural information from magnetic resonance imaging to investigate the feasibility of prostate diffuse optical tomography and spectroscopy: A simulation study.," Med. Phys. 0094-2405 10.1118/1.2400614 34, 266-274 (2007).
49. X. Zhou and T. C. Zhu, " Interstitial diffuse optical tomography using an adjoint model with linear sources.," Proc. SPIE 0277-786X 10.1117/12.762340 6845, 68450C-68459C (2008).
50. A. F. Low, G. J. Tearney, B. E. Bouma, and I. K. Jang, " Technology Insight: optical coherence tomography-Current status and future development.," Nat. Clin. Pract. Cardiovasc. Med. 3, 154-162 (2006). 1743-4297
51. B. W. Pogue, S. C. Davis, X. Song, B. A. Brooksby, H. Dehghani, and K. D. Paulsen, " Image analysis methods for diffuse optical tomography.," J. Biomed. Opt. 1083-3668 10.1117/1.2209908 11, 033001-033017 (2006).
52. A. P. Gibson, J. C. Hebden, and S. R. Arridge, " Recent advances in diffuse optical imaging.," Phys. Med. Biol. 0031-9155 10.1088/0031-9155/50/ 4/R01 50, R1-R43 (2005).
53. R. Richards-Kortum and E. Sevick-Muraca, " Quantitative optical spectroscopy for tissue diagnosis.," Annu. Rev. Phys. Chem. 0066-426X 10.1146/annurev.physchem.47.1.555 47, 555-606 (1996).
54. B. Swinson, W. Jerjes, M. El-Maaytah, P. Norris, and C. Hopper, " Optical techniques in diagnosis of head and neck malignancy.," Oral Oncol. 42, 221-228 (2006). 1368-8375
55. I. J. Bigio and S. G. Bown, " Spectroscopic sensing of cancer and cancer therapy: current status of translational research.," Cancer Biol. Ther. 3, 259-267 (2004). 1538-4047
56. J. C. Finlay, T. C. Zhu, A. Dimofte, D. Stripp, S. B. Malkowicz, T. M. Busch, and S. M. Hahn, " Interstitial fluorescence spectroscopy in the human prostate during motexafin lutetium-mediated photodynamic therapy.," Photochem. Photobiol. 0031-8655 10.1562/2005-10-04-RA-711 82, 1270-1278 (2006).
57. A. V. Hill, " The possible effects of the aggregation of the molecules of hemoglobin on its dissociation curves.," J. Physiol. (Proc.) 40, iv-vii (1910).
58. G. Yu, T. Durduran, C. Zhou, H. W. Wang, M. E. Putt, H. M. Saunders, C. M. Sehgal, E. Glatstein, A. G. Yodh, and T. M. Busch, " Noninvasive monitoring of murine tumor blood flow during and after photodynamic therapy provides early assessment of therapeutic efficacy.," Clin. Cancer Res. 11, 3543-3552 (2005). 1078-0432
59. H. W. Wang, M. E. Putt, M. J. Emanuele, D. B. Shin, E. Glatstein, A. G. Yodh, and T. M. Busch, " Treatment-induced changes in tumor oxygenation predict photodynamic therapy outcome.," Cancer Res. 0008-5472 10.1158/0008-5472.CAN-03-3632 64, 7553-7561 (2004).
60. M. C. Berenbaum, S. L. Akande, R. Bonnett, H. Kaur, S. Ioannou, R. D. White, and U. J. Winfield, " Meso-tetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivity.," Br. J. Cancer 54, 717-725 (1986). 0007-0920
61. I. P. van Geel, H. Oppelaar, Y. G. Oussoren, M. A. van der Valk, and F. A. Stewart, " Photosensitizing efficacy of mTHPC-PDT compared to photofrin-PDT in the RIF1 mouse tumour and normal skin.," Int. J. Cancer 60, 388-394 (1995). 0020-7136
62. W. Rauschning, I. B. Tan, and G. Dolivet, " Photodynamic therapy (PDT) with mTHPC in the palliation of advanced head and neck cancer in patients who have failed prior therapies and are unsuitable for radiatiotherapy, surgery or systemic chemotherapy.," J. Clin. Oncol. 22 (14), 5596 (2004).
63. M. Biel, " Advances in photodynamic therapy for the treatment of head and neck cancers.," Lasers Surg. Med. 38, 349-355 (2006). 0196-8092
64. L. B. Lovat, N. F. Jamieson, M. R. Novelli, C. A. Mosse, C. Selvasekar, G. D. Mackenzie, S. M. Thorpe, and S. G. Bown, " Photodynamic therapy with m-tetrahydroxyphenyl chlorin for high-grade dysplasia and early cancer in Barrett's columnar lined esophagus.," Gastrointest. Endosc. 62, 617-623 (2005). 0016-5107
65. J. Etienne, N. Dorme, G. Bourg-Heckly, P. Raimbert, and J. F. Flejou, " Photodynamic therapy with green light and m-tetrahydroxyphenyl chlorin for intramucosal adenocarcinoma and high-grade dysplasia in Barrett's esophagus.," Gastrointest. Endosc. 59, 880-889 (2004). 0016-5107
66. C. M. Moore, T. R. Nathan, W. R. Lees, C. A. Mosse, A. Freeman, M. Emberton, and S. G. Bown, " Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer.," Lasers Surg. Med. 0196-8092 10.1002/lsm.20275 38, 356-363 (2006).
67. S. P. Pereira, L. Ayaru, A. Rogowska, A. Moose, A. R. Hatfield, and S. G. Bown, " Photodynamic therapy of malignant biliary strictures using meso-tetrahydroxyphenylchlorin.," Eur. J. Gastroenterol. Hepatol. 19, 479-485 (2007). 0954-691X
68. A. Hansch, O. Frey, M. Gajda, G. Susanna, J. Boettcher, R. Brauer, and W. A. Kaiser, " Photodynamic treatment as a novel approach in the therapy of arthritic joints.," Lasers Surg. Med. 40, 265-272 (2008). 0196-8092
69. M. Triesscheijn, M. Ruevekamp, N. Antonini, H. Neering, F. A. Stewart, and P. Baas, " Optimizing meso-tetra-hydroxyphenyl-chlorin-mediated photodynamic therapy for basal cell carcinoma.," Photochem. Photobiol. 82, 1686-1690 (2006). 0031-8655
70. N. L. Oleinick, R. L. Morris, and I. Belichenko, " The role of apoptosis in response to photodynamic therapy: What, where, why, and how.," Photochem. Photobiol. Sci. 1474-905X 10.1039/b108586g 1, 1-21 (2002).
71. E. Buytaert, M. Dewaele, and P. Agostinis, " Molecular effectors of multiple cell death pathways initiated by photodynamic therapy.," Biochim. Biophys. Acta 1776, 86-107 (2007). 0006-3002
72. B. Chen, B. W. Pogue, P. J. Hoopes, and T. Hasan, " Vascular and cellular targeting for photodynamic therapy.," Crit. Rev. Eukaryot. Gene Expr. 16, 279-305 (2006). 1045-4403
73. T. M. Busch, " Local physiological changes during photodynamic therapy.," Lasers Surg. Med. 0196-8092 10.1002/lsm.20355 38, 494-499 (2006).
74. M. Korbelik, " PDT-associated host response and its role in the therapy outcome.," Lasers Surg. Med. 0196-8092 10.1002/lsm.20337 38, 500-508 (2006).
75. M. Korbelik, " Induction of tumor immunity by photodynamic therapy.," J. Clin. Laser Med. Surg. 14, 329-334 (1996). 1044-5471
76. P. Baas, L. Murrer, F. A. Zoetmulder, F. A. Stewart, H. B. Ris, N. van Zandwijk, J. L. Peterse, and E. J. Rutgers, " Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies.," Br. J. Cancer 76, 819-826 (1997). 0007-0920
77. L. K. Lee, C. Whiteburst, M. L. Pantelides, and J. V. Moore, " In situ comparison of 665 nm light and 633 nm wavelength light penetration in the human prostate gland.," Photochem. Photobiol. 62, 882-886 (1995). 0031-8655
78. M. L. Pantelides, C. Whitehurst, J. V. Moore, T. A. King, and N. J. Blacklock, " Photodynamic therapy for localised prostatic cancer: light penetration in the human prostate gland.," J. Urol. 143, 398-401 (1990). 0022-5347
79. T. C. Zhu, A. Dimofte, J. C. Finlay, D. Stripp, T. Busch, J. Miles, R. Whittington, S. B. Malkowicz, Z. Tochner, E. Glatstein, and S. M. Hahn, " Optical properties of human prostate at 732 nm measured in vivo during motexafin lutetium-mediated photodyanmic therapy.," Photochem. Photobiol. 0031-8655 10.1562/2004-06-25-RA-216.1 81, 96-105 (2005).
80. J. C. Finlay, D. L. Conover, E. L. Hull, and T. H. Foster, " Porphyrin bleaching and PDT-induced spectral changes are irradiance dependent in ALA-sensitized normal rat skin in vivo.," Photochem. Photobiol. 0031-8655 10.1562/0031-8655(2001)073<0054:PBAPIS>2.0.CO;2 73, 54-63 (2001).
81. J. C. Finlay, S. Mitra, and T. H. Foster, " In vivo mTHPC photobleaching in normal rat skin exhibits unique irradiance-dependent features.," Photochem. Photobiol. 0031-8655 10.1562/0031-8655(2002) 075<0282:IVMPIN>2.0.CO;2 75, 282-288 (2002).
82. J. C. Finlay, S. Mitra, and T. H. Foster, " Photobleaching kinetics of Photofrin in vivo and in multicell tumor spheroids indicate multiple simultaneous bleaching mechanisms.," Phys. Med. Biol. 0031-9155 10.1088/0031-9155/49/21/001 49, 4837-4860 (2004).
83. D. J. Robinson, H. S. de Bruijn, N. van der Veen, M. R. Stringer, S. B. Brown, and W. M. Star, " Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: The effect of light dose and irradiance and the resulting biological effect.," Photochem. Photobiol. 0031-8655 10.1111/j.1751-1097.1998.tb05177.x 67, 140-149 (1998).
84. W. J. Cottrell, A. Oseroff, and T. H. Foster, " Portable instrument that integrates irradiation with fluorescence and reflectance spectroscopies during clinical photodynamic therapy of cutaneous disease.," Rev. Sci. Instrum. 0034-6748 10.1063/1.2204617 77, 064302 (2006).
85. K. K.-H. Wang, S. Mitra, and T. H. Foster, " A comprehensive mathematical model of microscopic dose deposition in photodynamic therapy.," Med. Phys. 0094-2405 10.1118/1.2401041 34, 282-293 (2007).
86. J. S. Dysart and M. S. Patterson, " Photobleaching kinetics, photoproduct formation, and dose estimation during ALA induced PpIX PDT of MLL cells under well oxygenated and hypoxic conditions.," Photochem. Photobiol. Sci. 5, 73-81 (2006). 1474-905X
87. Y. Qin, D. Xing, S. Luo, J. Zhou, X. Zhong, and Q. Chen, " Feasibility of using fluoresceinyl Cypridina luciferin analog in a novel chemiluminescence method for real-time photodynamic therapy dosimetry.," Photochem. Photobiol. 0031-8655 10.1562/2005-05-20-RA-536 81, 1534-1538 (2005).
88. M. T. Jarvi, M. J. Niedre, M. S. Patterson, and B. C. Wilson, " Singlet oxygen luminescence dosimetry (SOLD) for photodynamic therapy: current status, challenges and future prospects.," Photochem. Photobiol. 0031-8655 10.1562/2006-05-03-IR-891 82, 1198-1210 (2006).
89. K. Stefflova, J. Chen, and G. Zheng, " Using molecular beacons for cancer imaging and treatment.," Front. Biosci. 12, 4709-4721 (2007). 1093-9946
90. H. Minn, " PET and SPECT in low-grade glioma.," Eur. J. Radiol. 56, 171-178 (2005). 0720-048X
91. N. Solban, I. Rizvi, and T. Hasan, " Targeted photodynamic therapy.," Lasers Surg. Med. 38, 522-531 (2006). 0196-8092
92. D. Schrama, R. A. Reisfeld, and J. C. Becker, " Antibody targeted drugs as cancer therapeutics.," Nat. Rev. Drug Discov. 5, 147-159 (2006). 1474-1776
93. R. M. Sharkey and D. M. Goldenberg, " Targeted therapy of cancer: New prospects for antibodies and immunoconjugates.," Ca-Cancer J. Clin. 56, 226-243 (2006). 0007-9235
94. M. G. del Carmen, I. Rizvi, Y. Chang, A. C. Moor, E. Oliva, M. Sherwood, B. Pogue, and T. Hasan, " Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo.," J. Natl. Cancer Inst. 97, 1516-1524 (2005). 0027-8874
95. K. A. Cengel, S. M. Hahn, and E. Glatstein, " C225 and PDT combination therapy for ovarian cancer: the play's the thing.," J. Natl. Cancer Inst. 97, 1488-1489 (2005). 0027-8874
96. C. J. Gomer, A. Ferrario, M. Luna, N. Rucker, and S. Wong, " Photodynamic therapy: Combined modality approaches targeting the tumor microenvironment.," Lasers Surg. Med. 38, 516-521 (2006). 0196-8092
97. S. K. Bisland, L. Lilge, A. Lin, R. Rusnov, and B. C. Wilson, " Metronomic photodynamic therapy as a new paradigm for photodynamic therapy: Rationale and preclinical evaluation of technical feasibility for treating malignant brain tumors.," Photochem. Photobiol. 0031-8655 10.1562/2004-03-05-RA-100.1 80, 22-30 (2004).
98. J. Li, T. C. Zhu, X. Zhou, A. Dimofte, and J. C. Finlay, " Integrated light dosimetry system for prostate photodynamic therapy.," Proc. SPIE 0277-786X 10.1117/12.763806 6845, 68450Q-68458Q (2008).
99. L. Vesselov, W. Whittington, and L. Lilge, " Design and performance of thin cylindrical diffusers created in Ge-doped multimode optical fibers.," Appl. Opt. 0003-6935 10.1364/AO.44.002754 44, 2754-2758 (2005).
100. A. Rendon, R. Weersink, and L. Lilge, " Towards conformal light delivery using tailored cylindrical diffusers: attainable light dose distributions.," Phys. Med. Biol. 0031-9155 10.1088/0031-9155/51/23/001 51, 5967-5975 (2006).
101. G. Yu, T. Durduran, C. Zhou, T. C. Zhu, J. C. Finlay, T. M. Busch, S. B. Malkowicz, S. M. Hahn, and A. G. Yodh, " Real-time in situ monitoring of human prostate photodynamic therapy with diffuse light.," Photochem. Photobiol. 0031-8655 10.1562/2005-10-19-RA-721 82, 1279-1284 (2006).
102. E. Clo, J. W. Snyder, P. R. Ogilby, and K. V. Gothelf, " Control and selectivity of photosensitized singlet oxygen production: challenges in complex biological systems.," ChemBioChem 8, 475-481 (2007). 1439-4227
103. Y. Chen, A. Gryshuk, S. Achilefu, T. Ohulchansky, W. Potter, T. Zhong, J. Morgan, B. Chance, P. N. Prasad, B. W. Henderson, A. Oseroff, and R. K. Pandey, " A novel approach to a bifunctional photosensitizer for tumor imaging and phototherapy.," Bioconjug. Chem. 16, 1264-1274 (2005). 1043-1802
104. R. K. Pandey, L. N. Goswami, Y. Chen, A. Gryshuk, J. R. Missert, A. Oseroff, and T. J. Dougherty, " Nature: A rich source for developing multifunctional agents. Tumor-imaging and photodynamic therapy.," Lasers Surg. Med. 0196-8092 10.1002/lsm.20352 38, 445-467 (2006).
105. G. Zheng, J. Chen, K. Stefflova, M. Jarvi, H. Li, and B. C. Wilson, " Photodynamic molecular beacon as an activatable photosensitizer based on protease-controlled singlet oxygen quenching and activation.," Proc. Natl. Acad. Sci. U.S.A. 104, 8989-8994 (2007). 0027-8424
106. S. Mitra and T. H. Foster, " Photophysical parameters, photosensitizer retention and tissue optical properties completely account for the higher photodynamic efficacy of meso-tetra-hydroxyphenyl-chlorin vs Photofrin.," Photochem. Photobiol. 0031-8655 10.1562/2005-02-22-RA-447R.1 81, 849-859 (2005).
107. A. Johansson, J. Axelsson, S. Andersson-Engels, and J. Swartling, " Realtime light dosimetry software tools for interstitial photodynamic therapy of the human prostate.," Med. Phys. 0094-2405 10.1118/1.2790585 34, 4309-4321 (2007).
108. T. C. Zhu, J. Li, J. C. Finlay, A. Dimofte, D. Stripp, B. S. Malkowicz, and S. M. Hahn, " In vivo light dosimetry of interstitial PDT of human prostate.," Proc. SPIE 6139, 61390L-61401L (2006). 0277-786X
109. J. Li and T. C. Zhu, " Determination of in vivo light fluence distribution in heterogeneous prostate during photodyanmic therapy.," Phys. Med. Biol. 0031-9155 10.1088/0031-9155/53/8/007 53, 2103-2114 (2008).
110. M. D. Altschuler, T. C. Zhu, J. Li, and S. M. Hahn, " Optimized interstitial PDT prostate treatment planning with the Cimmino feasibility algorithm.," Med. Phys. 0094-2405 10.1118/1.2107047 32, 3524-3536 (2005).
111. M. S. Patterson, B. C. Wilson, and R. Graff, " In vivo tests of the concept of photodynamic threshold dose in norma rate liver photosensitized by aluminum chlorosulphonated phthalocyanine.," Photochem. Photobiol. 0031-8655 10.1111/j.1751-1097.1990.tb01720.x 51, 343-349 (1990).
112. I. Georgakoudi and T. H. Foster, " Singlet oxygen- versus nonsinglet oxygen-mediated mechanisms of sensitizer photobleaching and their effects on photodynamic dosimetry.," Photochem. Photobiol. 0031-8655 10.1111/j.1751-1097.1998.tb09463.x 67, 612-625 (1998).
113. A. P. Castano, P. Mroz, and M. R. Hamblin, " Photodynamic therapy and anti-tumour immunity.," Nat. Rev. Cancer 6, 535-545 (2006). 1474-175X
114. S. O. Gollnick, L. Vaughan, and B. W. Henderson, " Generation of effective antitumor vaccines using photodynamic therapy.," Cancer Res. 62, 1604-1608 (2002). 0008-5472
115. M. Korbelik and J. Sun, " Photodynamic therapy-generated vaccine for cancer therapy.," Cancer Immunol. Immunother. 55, 900-909 (2006). 0340-7004
116. B. W. Henderson, S. O. Gollnick, J. W. Snyder, T. M. Busch, P. C. Kousis, R. T. Cheney, and J. Morgan, " Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors.," Cancer Res. 0008-5472 10.1158/0008-5472.CAN-03-3513 64, 2120-2126 (2004).